Low BMI Is a Predictor of Death for TAVI

Courtesy of Dr. Carlos Fava.

 

low BMI death TAVI

 

Body mass index (BMI) has always played an important role in heart surgery. However, there is little evidence on BMI effects on TAVI.

This study included 491 patients, which were divided according to BMI into:

 

  • low (<20 Kg/m2 )
  • normal (20-24.9 Kg/m2 )
  • overweight (25-30 Kg/m2 )
  • obese (>30 Kg/m2 )

 

BMI was low in 43 patients (8.7%), normal in 148 (30.1%), overweight in 162 (33%) and obese in 138 (28.1%).

Obese patients were younger, diabetes was more frequent among morbid obese, but there were fewer with prior MI.

STS score was inversely associated with BMI:

Low weight: 11.4±4.9

Normal: 9.1±4.8

Overweight: 8.4±4.3

Obesity: 7.9±4

[p<0.001]

Ejection fraction was also inversely associated to BMI, but the opposite happened with the aortic valve area.

There was no difference in procedural success, except for longer fluoroscopy time in the group with morbid obesity. Vascular complications and transfusions (VARC-2 criteria) were higher in the low BMI group, while acute kidney injury was higher in the highest BMI group.

At one year follow up, all-cause mortality was higher in the low BMI group compared to the other 3 groups (p=0.003).

In multivariable analyzis, BMI <20 Kg/mwas an independent predictor of mortality (HR=2.45; p=0.01).

 

Conclusion

Body mass index <20 Kg/mshould be considered a fragility marker during screening for TAVI of patients with severe aortic stenosis, since it is associated to high mortality, while obese patients presented similar mortality risk to those of normal weight.

 

Editorial Comment

BMI should be included as part of patient screening routine procedures when considering TAVI, because it is associated with in-hospital complications and mortality. BMI could be used as a sign of fragility. We should controlling fluid balance in morbid obesity because these patients present higher kidney failure rate after implantation, which can be associated to loss of volume, hard to recover immediately after procedure.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Body Mass Index Association with Survival in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement

Reference: Edward Koifman, et al. Cateheterization cardiovascular Intervention 2016;88:118-124

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...